Log in

LON:SLAStandard Life Aberdeen Share Price, Forecast & News

GBX 271.10
-4.50 (-1.63 %)
(As of 08/14/2020 07:25 AM ET)
Today's Range
Now: GBX 271.10
50-Day Range
MA: GBX 262.80
52-Week Range
Now: GBX 271.10
Volume4.45 million shs
Average Volume9.33 million shs
Market Capitalization£6.10 billion
P/E Ratio24.42
Dividend Yield8.28%
Standard Life Aberdeen plc provides asset management services in the United Kingdom, Europe, North America, and Asia. The company offers investment solutions and funds; long-term savings and investment products to individual and corporate customers; and life insurance and savings products. It provides its products through institutional, wholesale, and retail distribution channels. It also makes real estate investments. The company was formerly known as Standard Life plc and changed its name to Standard Life Aberdeen plc in August 2017. Standard Life Aberdeen plc was founded in 1825 and is headquartered in Edinburgh, United Kingdom.
Read More
Standard Life Aberdeen logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.98 out of 5 stars

Industry, Sector and Symbol

Industry Insurance - Life



Sales & Book Value

Annual Sales£3.85 billion
Cash FlowGBX 73 per share
Book ValueGBX 287.10 per share



Outstanding Shares2,250,820,096
Market Cap£6.10 billion
Next Earnings DateN/A
OptionableNot Optionable
GBX 271.10
-4.50 (-1.63 %)
(As of 08/14/2020 07:25 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SLA News and Ratings via Email

Sign-up to receive the latest news and ratings for SLA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Standard Life Aberdeen (LON:SLA) Frequently Asked Questions

How has Standard Life Aberdeen's stock been impacted by Coronavirus (COVID-19)?

Standard Life Aberdeen's stock was trading at GBX 244.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SLA stock has increased by 10.9% and is now trading at GBX 271.10.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Standard Life Aberdeen?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Standard Life Aberdeen in the last year. There are currently 5 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Standard Life Aberdeen

How often does Standard Life Aberdeen pay dividends? What is the dividend yield for Standard Life Aberdeen?

Standard Life Aberdeen declared a dividend on Friday, August 7th. Shareholders of record on Thursday, August 20th will be paid a dividend of GBX 7.30 per share on Tuesday, September 29th. This represents a yield of 2.76%. The ex-dividend date is Thursday, August 20th. The official announcement can be seen at this link.
View Standard Life Aberdeen's dividend history

What price target have analysts set for SLA?

13 equities research analysts have issued 12 month price targets for Standard Life Aberdeen's shares. Their forecasts range from GBX 225 to GBX 300. On average, they anticipate Standard Life Aberdeen's share price to reach GBX 253 in the next twelve months. This suggests that the stock has a possible downside of 6.7%.
View analysts' price targets for Standard Life Aberdeen

Has Standard Life Aberdeen been receiving favorable news coverage?

Media coverage about SLA stock has been trending positive recently, according to InfoTrie. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Standard Life Aberdeen earned a news sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.
View the latest news about Standard Life Aberdeen

Who are some of Standard Life Aberdeen's key competitors?

What other stocks do shareholders of Standard Life Aberdeen own?

Who are Standard Life Aberdeen's key executives?

Standard Life Aberdeen's management team includes the following people:
  • Mr. Norman Keith Skeoch, CEO & Exec. Director (Age 62)
  • Mr. William John Rattray MA, CA, CFO & Exec. Director (Age 61)
  • Mr. Roderick Louis Paris, Chief Investment Officer & Exec. Director (Age 60)
  • Sir Gerald Edgar Grimstone, Advisor (Age 69)
  • Mr. Mark Dixon, CTO & Chief Information Officer

What is Standard Life Aberdeen's stock symbol?

Standard Life Aberdeen trades on the London Stock Exchange (LON) under the ticker symbol "SLA."

How do I buy shares of Standard Life Aberdeen?

Shares of SLA and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Standard Life Aberdeen's stock price today?

One share of SLA stock can currently be purchased for approximately GBX 271.10.

How big of a company is Standard Life Aberdeen?

Standard Life Aberdeen has a market capitalization of £6.10 billion and generates £3.85 billion in revenue each year. Standard Life Aberdeen employs 6,192 workers across the globe.

What is Standard Life Aberdeen's official website?

The official website for Standard Life Aberdeen is www.standardlifeaberdeen.com.

How can I contact Standard Life Aberdeen?

Standard Life Aberdeen's mailing address is Standard Life House, 30 Lothian Road, EDINBURGH, EH1 2DH, United Kingdom. The company can be reached via phone at +44-131-2252552.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.